Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. - Wikidata - wikimedia - TriplyDB

Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States.

Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States.

http://www.wikidata.org/entity/Q33998217

about

What Is the Best Definitive Treatment for Graves’ Disease? A Systematic Review of the Existing Literature Radioiodine therapy versus antithyroid medications for Graves' disease Adjunctive antithyroid drugs in radioiodine therapy for hyperthyroidism Radioiodine therapy versus anti-thyroid medications for Graves' disease Adjunctive antithyroid drugs in radioiodine therapy for hyperthyroidism The diagnosis and management of hyperthyroidism in Korea: consensus report of the korean thyroid association Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016 Current and emerging treatment options for Graves' hyperthyroidism.Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab Effect of Antithyroid Therapies on Bone and Body Composition: A Prospective, Randomized, Clinical Study Comparing Antithyroid Drugs with Radioiodine Therapy.Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008.Total thyroidectomy: a safe and effective treatment for Graves' disease.Patient knowledge of antithyroid drug-induced agranulocytosis Failure of radioactive iodine in the treatment of hyperthyroidism.Diagnosis and treatment of Graves disease.Graves' ophthalmopathy as an indication increased the risk of hypoparathyroidism after bilateral thyroidectomy Trends in diagnostic and therapeutic criteria in Graves' disease in the last 10 years.Current concepts in graves' disease.The safety and efficacy of antithyroid drugs.Thyroid storm masked by hemodialysis and glucocorticoid therapy in a patient with rheumatoid arthritis Change in Practice over Four Decades in the Management of Graves' Disease in Scotland.Sepsis mimicking thyroid storm in a patient with methimazole-induced agranulocytosis Outcome of 131I therapy in hyperthyroidism using a 550MBq fixed dose regimen.Effectiveness of Fixed Dose Radioactive Iodine (RAI) for the Treatment of Hyperthyroidism: Experience of a Teaching Hospital in South West Nigeria.Greater Efficacy of Total Thyroidectomy versus Radioiodine Therapy on Hyperthyroidism and Thyroid-Stimulating Immunoglobulin Levels in Patients with Graves' Disease Previously Treated with Antithyroid Drugs.Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use Diagnosis and management of Graves disease: a global overview.An update on the medical treatment of Graves' hyperthyroidism.Radioiodine therapy versus antithyroid drugs in Graves' disease: a meta-analysis of randomized controlled trials.Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any).Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.Comparative analysis of radioactive iodine versus thyroidectomy for definitive treatment of Graves disease.A 2013 European survey of clinical practice patterns in the management of Graves' disease.Radioiodine therapy in patients with Graves' disease and the effects of prior carbimazole therapy.Serum 25-hydroxyvitamin D might be an independent prognostic factor for Graves disease recurrence Hyperthyroidism and Graves' disease: Is an ultrasound examination needed?Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?A study of serum IgG4 levels in the clinical metamorphosis of autoimmune thyroid disease.Mean Platelet Volume in Graves' disease: A Sign of Hypermetabolism Rather than Autoimmunity?Detection of low titre TBII in patients with Graves' disease using recombinant human TSH receptor.

P2860

Q22306156-62AC88E1-285E-4D61-8F44-67E24EC58075 Q24186122-8F4D8E6E-A674-4A52-8348-F49072B3E057 Q24195154-40020835-2AF1-4C20-8FBF-368F9C0A0E5A Q24201257-4DD0DE3A-81B0-46F6-8B61-ABDD209C35C0 Q24246696-8624811B-F4BB-485E-BD5F-889281211B97 Q26823622-C76B3D21-84E3-4B1C-9886-000B4579AF78 Q33594405-B0A98292-F89C-4D05-A118-A00E62187603 Q33635029-15B03632-0357-4B62-A9C9-ABF6D5DF8417 Q33741009-F0F7D110-D2FF-4AB9-AB1C-68C0EA7B96C1 Q33815492-417D12F4-AD5D-47A3-8378-45A6825EB6DC Q33849471-01B505AA-6951-4CD6-ADD2-A6EB3E0B21D7 Q34900566-A6207A38-D10D-4D26-9C83-EE09CB7B3C73 Q35029667-67BB89B3-150C-4B4F-B64E-8E4E6B606801 Q35088255-F30F78AE-183E-4515-8907-C238E9E43A3C Q35169457-E4963CFD-F8BE-4FEF-8070-3DD95D9B563C Q35206790-E1B9DA75-C552-48DE-AA65-F00046F053C4 Q35508549-5721EFF3-6F5A-4D33-B13C-AEFE1A8EF551 Q36328020-A2D376C3-FE86-491B-8198-6ADEF8F38267 Q36349745-DB9B7E96-D954-416D-AF0E-FE69443A6BF0 Q36350093-ED3821BB-FFCC-4CBC-9191-149DA79F0641 Q36995936-546B912B-987C-4518-8380-61EAD7833970 Q37078129-5F65A122-85CA-4B08-B89C-B09D653E6A28 Q37131301-D3B9C361-105D-4716-8F9C-2F7EE6B03E3A Q37137702-B36F297F-87F8-4E5B-B817-5E5C49D6ABE9 Q37290885-23DDDBD0-15F5-458B-9670-6C70F52CF494 Q37420857-DD8C9812-A85B-4E06-8093-111CE64FCACE Q38152621-47BDC691-DF1C-42E5-BBA2-E12A34998D6C Q38245840-D535E095-F10A-4007-8667-4C7A7A030B5E Q38379826-83986F4F-EA4B-4647-8FEC-F639F1505334 Q38869637-B63EC29F-46CA-43D2-BB6E-8348DB7CDA29 Q38888403-207E44E4-0EB8-4200-8422-7BDE141F511D Q39013482-F14830B8-BA0D-49F4-8AAD-C6CCD55382EB Q41592139-A35DA001-E2CD-44A3-B459-905C441C8B91 Q41870333-76D26B35-4B38-44C9-9521-DC77B7DE705B Q41985344-854C4AF7-13AF-46AA-985C-D5B73D046487 Q42370015-6C5C44A4-260B-4646-BC83-D7A33E12351E Q42609478-9AEC80E5-0C24-4EBD-830F-776A7184199B Q42656311-9E763F33-B2E9-40DD-8FE0-D29C6C058B0C Q42669637-F6FA2928-8719-4F65-9C8B-4BAF7A6A0DAB Q44086626-8D1C9764-D5FB-4025-87EE-426AA9B942E1

P2860

Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States.

http://www.wikidata.org/entity/Q33998217

description

1991 nî lūn-bûn

@nan

1991 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1991 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

name

Differences and similarities i ...... Japan, and the United States.

@ast

Differences and similarities i ...... Japan, and the United States.

@en

type

label

Differences and similarities i ...... Japan, and the United States.

@ast

Differences and similarities i ...... Japan, and the United States.

@en

prefLabel

Differences and similarities i ...... Japan, and the United States.

@ast

Differences and similarities i ...... Japan, and the United States.

@en

P1433

Q33998217-1DAD7840-7A17-4895-A519-BBB3A68D115B

P1476

Q33998217-AE95585B-E812-4F7F-BE75-161E8A5D20C2

P2093

Q33998217-793BC630-9031-4B47-A9D0-A47ACB4FA6F3

Q33998217-7F7B1BD1-C97D-4A0D-98D9-15FEF4F0D580

Q33998217-A14882CF-BC6D-45B1-B491-45E0350724BA

Q33998217-AFF77165-DB09-4539-87E4-372688B00EFB

Q33998217-BE4C5B02-1FC0-49F2-AA40-F629E3006F37

Q33998217-E7D852F6-BA52-4E6B-9E90-94714256E36E

Q33998217-F482A098-EF46-4D24-8FE5-991BCE21AE7C

P304

Q33998217-17B213D3-04B9-4445-86A8-0F573196A650

P31

Q33998217-F586B13B-C9B2-42AA-A553-FAD6E1DFB0E5

P356

Q33998217-1DDD5542-5B01-4888-9797-0E1B74194ACF

P433

Q33998217-0833216E-2642-443D-A684-29FFAAC6E2BB

P478

Q33998217-36370B46-FE1B-498B-9BDF-CA156EF062C3

P577

Q33998217-DF6CC1EA-E659-4131-9386-0A2E5CD6CAC2

P698

Q33998217-DF976858-366B-4E47-8603-B0BA77F1FD40

P356

P1433

P1476

Differences and similarities i ...... Japan, and the United States.

@en

P2093

Glinoer D

http://www.w3.org/2001/XMLSchema#string

Izumi M

http://www.w3.org/2001/XMLSchema#string

Lagasse R

http://www.w3.org/2001/XMLSchema#string

Nagataki S

http://www.w3.org/2001/XMLSchema#string

Nagayama Y

http://www.w3.org/2001/XMLSchema#string

Solomon B

http://www.w3.org/2001/XMLSchema#string

Wartofsky L

http://www.w3.org/2001/XMLSchema#string

P304

129-135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/THY.1991.1.129

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

1991-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1688014

http://www.w3.org/2001/XMLSchema#string